Massachusetts Institute of Technology
Feng Zhang is a molecular biologist at the Broad Institute and MIT who was among the first to adapt CRISPR-Cas9 for genome editing in mammalian cells. He has also developed novel CRISPR systems including Cas13 for RNA editing.
118
H-INDEX
310
PUBLICATIONS
42
GRANTS
45
PATENTS
INDUSTRY TIES
Editas Medicine
Beam Therapeutics
Arbor Biotechnologies
Sherlock Biosciences
TRY IT
Install the CLI and run your first search in under a minute. No account required to explore.
npx sci-buy@latest COPIED